Author/Authors :
Faezi, Sobhan Medical Biotechnology Research Center - Faculty of Paramedicine - Guilan University of Medical Sciences, Rasht, Iran , Nikokar, Iraj Medical Biotechnology Research Center - Faculty of Paramedicine - Guilan University of Medical Sciences, Rasht, Iran , Elmi, Ali Medical Biotechnology Research Center - Faculty of Paramedicine - Guilan University of Medical Sciences, Rasht, Iran , Ghasemi, Yusuf Medical Biotechnology Research Center - Faculty of Paramedicine - Guilan University of Medical Sciences, Rasht, Iran , Farahbakhsh, Mojtaba Medical Biotechnology Research Center - Faculty of Paramedicine - Guilan University of Medical Sciences, Rasht, Iran , Salimi Chirani, Alireza Department of Medical Microbiology - Faculty of Medicine - Shahid Beheshty University of Medical Science, Tehran, Iran , Mahdavi, Mehdi Department of Immunology - Pasteur Institute of Iran, Tehran, Iran
Abstract :
Background: Type 4 pili (T4P) is an important virulence factor of Pseudomonas
aeruginosa (P. aeruginosa). T4P pass the outer membrane through a large oligomeric
channel made of a single PilQ protein that is most highly conserved at their C-termini.
To develop a functional vaccine that can be used in clinical application, the secretin
domain of the PilQ (PilQ380-706) was produced as a recombinant protein.
Methods: A 981 bp fragment of C-terminal of the pilQ secretin (pilQ1138-2118) from was
designed into the prokaryotic expression vector pET28a. The presence of the pilQ1138-2118
gene in the recombinant construct (pET28a/pilQ) was assessed by double digestion
and PCR. After transformation, expression of the recombinant PilQ was induced by
addition of IPTG. The expressed recombinant protein was purified by a modified
method using a HisTrap affinity column and finally confirmed by SDS-PAGE. The
functional activities of the produced PilQ380-706 confirmed by Western blot analysis
and twitching inhibition assay.
Results: The PCR and enzymatic digestion results showed the presence of the pilQ1138-
2118 gene in the construct. The protein electrophoresis showed that the molecular
weight of the recombinant PilQ380-706 is approximately 37 kDa. The Western blot
analysis confirmed the specificity of specific IgG against the PilQ380-706 protein. The
PilQ380-706 protein showed high biological activity in all of these standard assays.
Conclusion: Since, the PilQ380-706 protein plays an important role in the biogenesis of
pili; and thus, the primary establishment of P. aeruginosa; it seems that it can be used
as a candidate vaccine or an adjuvant in the future studies.